z-logo
open-access-imgOpen Access
Letter by Keidar and Gamliel-Lazarovich Regarding Article, “Effects of A Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial”
Author(s) -
Shlomo Keidar,
Aviva Gamliel-Lazarovich
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.080341
Subject(s) - aldosterone , medicine , aldosterone synthase , placebo , double blind , randomized controlled trial , placebo controlled study , pharmacology , blood pressure , endocrinology , pathology , renin–angiotensin system , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom